Editas Medicine (EDIT) Earnings Date, Estimates & Call Transcripts $3.57 -0.31 (-7.99%) Closing price 04:00 PM EasternExtended Trading$3.60 +0.03 (+0.70%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine Earnings Summary Editas Medicine issued Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.63, which missed analysts' consensus estimates of -$0.41 by $0.22. Quarterly revenue was reported to be $3.58 million, above analyst estimates of $1.81 million. With a trailing EPS of -$2.85, Editas Medicine's earnings are expected to grow next year, from ($2.71) to ($1.66) per share. Upcoming Q3 Earnings DateNov. 3Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.41 Actual EPS (Aug. 12) -$0.63 Missed By -$0.22 Actual Revenue (Aug. 12) $3.58MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)EDIT Upcoming EarningsEditas Medicine's Q3 2025 earnings is scheduled for Monday, November 3, 2025, with a conference call scheduled at 7:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2025 Earnings ReportPowered by Get Editas Medicine Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Editas Medicine and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataEDIT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EDIT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Editas Medicine Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.63-$0.46-$0.55Q2 20253-$0.46-$0.33-$0.37Q3 20252-$0.43-$0.14-$0.29Q4 20252-$0.19-$0.14-$0.17 FY 2025 10 -$1.71 -$1.07 -$1.37 Q1 20261-$0.45-$0.45-$0.45Q2 20261-$0.39-$0.39-$0.39Q3 20261-$0.48-$0.48-$0.48Q4 20261-$0.18-$0.18-$0.18 Editas Medicine Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/3/2025(Estimated)-------8/12/2025Q2 2025-$0.41-$0.63 -$0.22-$0.63$1.81M$3.58M5/12/2025Q1 2025-$0.51-$0.43+$0.08-$0.92$0.79M$4.66M3/5/2025Q4 2024-$0.39-$0.55 -$0.16-$0.55$37.17M$30.60M11/4/2024Q3 2024-$0.75-$0.75--$0.75$3.93M$0.06M8/7/2024Q2 2024-$0.70-$0.82 -$0.12-$0.82$4.78M$0.51M5/8/2024Q1 2024-$0.63-$0.76 -$0.13-$0.76$11.14M$1.10M2/28/2024Q4 2023-$0.52-$0.23+$0.29-$0.23$4.84M$60.00M11/3/2023Q3 2023-$0.64-$0.55+$0.09-$0.55$3.70M$5.34M Editas Medicine Earnings - Frequently Asked Questions When is Editas Medicine's earnings date? Editas Medicine has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 3rd, 2025 based off last year's report dates. Learn more on EDIT's earnings history. Did Editas Medicine beat their earnings estimates last quarter? In the previous quarter, Editas Medicine (NASDAQ:EDIT) missed the analysts' consensus estimate of ($0.41) by $0.22 with a reported earnings per share (EPS) of ($0.63). Learn more on analysts' earnings estimate vs. EDIT's actual earnings. How much revenue does Editas Medicine generate each year? Editas Medicine (NASDAQ:EDIT) has a recorded annual revenue of $38.90 million. How much profit does Editas Medicine generate each year? Editas Medicine (NASDAQ:EDIT) has a recorded net income of -$237.09 million. EDIT has generated -$2.85 earnings per share over the last four quarters. What is Editas Medicine's EPS forecast for next year? Editas Medicine's earnings are expected to grow from ($2.71) per share to ($1.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies Beam Therapeutics Earnings Results CRISPR Therapeutics Earnings Results Intellia Therapeutics Earnings Results atai Life Sciences Earnings Results Amylyx Pharmaceuticals Earnings Results Sana Biotechnology Earnings Results Zymeworks Earnings Results Syndax Pharmaceuticals Earnings Results Trevi Therapeutics Earnings Results Maze Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetGoldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 Earnings This page (NASDAQ:EDIT) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump cannot stop this trainThe Nobel Committee just confirmed what free-market thinkers have long argued — that true wealth isn’t built t...Porter & Company | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredBitcoin is dead?Bitcoin’s historic run may be ending — and Weiss Ratings’ Juan Villaverde, who’s nailed every major crypto bul...Weiss Ratings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
